Articles by Cynthia Challener, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Cynthia Challener, PhD

Automating Online Sampling of Bioprocesses

The Modular Automated Sampling Technology platform consists of a sterile sampling system, a sample scheduler and navigator for automated sampling and delivery of samples to analytical instruments, and a data-management system.
Jul 2, 2014

The Modular Automated Sampling Technology platform allows sampling of bioreactors.

The Mainstreaming of Continuous Flow API Synthesis

The pharma industry is moving toward commercial-scale continuous processes for small-molecule API manufacturing.
Jul 2, 2014

The pharma industry is moving toward commercial-scale continuous processes for small-molecule API manufacturing.

Advances in Real-Time Bioreactor Sampling

The Modular Automated Sampling Technology platform takes online samples from bioreactors and transfers them directly to analytical devices.
Jun 18, 2014

The Modular Automated Sampling Technology platform takes online samples from bioreactors and transfers them directly to analytical devices.

Seeking Alternative Catalyst Solutions

Transition metal-containing catalysts are widely used in organic synthesis, but many are based on expensive, rare metals. Researchers are seeking more sustainable alternatives.
Jun 2, 2014

Transition metal-containing catalysts are widely used in organic synthesis, but many are based on expensive, rare metals. Researchers are seeking more sustainable alternatives.

Alternatives to Precious Metal Catalysts Sought

Industry seeks alternatives to costly and toxic precious metals used to form the catalysts for organic synthesis.
Jun 2, 2014

Industry seeks alternatives to costly and toxic precious metals used to form the catalysts for organic synthesis.

Cocrystals: Industry Takes a Wait-and-See Approach

The perceived risks associated with cocrystals may be slowing progress of their industrial application.
May 30, 2014

The perceived risks associated with cocrystals may be slowing progress of their industrial application.

HPAPIs: Fast-growing Segment Presents Challenges and Opportunities

Appropriate process design and engineering are critical for the production of small-molecule and biologic HPAPIs.
May 30, 2014

Appropriate process design and engineering are critical for the production of small-molecule and biologic HPAPIs.

Packaging Becomes Enabler for Biopharmaceuticals

May 2, 2014

Once an afterthought, packaging has now become an essential component of biopharmaceutical product development and marketing.

Scientific Advances in Cocrystals are Offset by Regulatory Uncertainty

Drug developers are taking a wait-and-see approach to the use of cocrystals.
May 2, 2014

Drug developers are taking a wait-and-see approach to the use of cocrystals.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
FindPharma Custom Search
Click here